Rat IL-6 Platinum ELISA

Description: The rat IL-6 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of rat IL-6. The rat IL-6 ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Interleukin-6 (IL-6) is a multi-functional cytokine that regulates immune responses, acute phase reactions and hematopoiesis and may play a central role in host defense mechanisms.
IL-6 is usually not produced constitutively by normal cells, but its expression is readily induced by a variety of cytokines, lipopolysaccharide or viral infections. IL-6 is a pleiotropic cytokine produced by a variety of cells. It acts on a wide range of tissues, exerting growth-induction, growth-inhibition, and differentiation respectively, depending on the nature of the target cells.

IL-6 is involved in

- the induction of B-cell differentiation
- the induction of acute phase proteins in liver cells
- growth promotion of myeloma/plasmacytoma/hybridoma cells
- induction of IL-2 and IL-2 receptor expression
- proliferation and differentiation of T cells
- inhibition of cell growth of certain myeloid leukemic cell lines and induction of their differentiation to macrophages
- enhancement of IL-3-induced multipotential colony cell formation in hematopoietic stem cells and induction of maturation of megakaryocytes as a thrombopoietic factor
- induction of mesangial cell growth
- induction of neural differentiation of PC 12 cells and
- induction of keratinocyte growth

The abnormal production of IL-6 was first suggested to be related to polyclonal B-cell activation with autoantibody production in patients with cardiac myxoma. Since then, IL-6 has been suggested to be involved in the pathogenesis of a variety of diseases. Measurement of IL-6 levels in serum and other body fluids thus provides more detailed insights into various pathological situations.

Citations: Szabolcs A,Reiter RJ,Letoha T,Hegyi P,Papai G,Varga I,Jarmay K,Kaszaki J,Sari R,Rakonczay Z Jr,Lonovics J,Takacs T.. Effect of melatonin on the severity of L-arginine-induced experimental acute pancreatitis in rats. World J Gastroenterol. 2006;12:251-258. (Link)

Akkaya,Pinar; Onalan,Gogsen; Haberal,Nihan; Bayraktar,Nilufer; Mulayim,Baris; Zeyneloglu,Hulusi B.. Doxycycline causes regression of endometriotic implants: a rat model. Human Reproduction 2009;dep106(Link)

Mikaelian,Igor; Coluccio,Denise; Morgan,Kevin T.; Johnson,Teona; Ryan,Amber L.; Rasmussen,Erik; Nicklaus,Rosemary; Kanwal,Charu; Hilton,Holly; Frank,Karl; Fritzky,Luke; Wheeldon,Eric B.. Temporal Gene Expression Profiling Indicates Early Up-regulation of Interleukin-6 in Isoproterenol-induced Myocardial Necrosis in Rat. Toxicologic Pathology 2008;36:256-264. (Link)

Yang,Ying; Mou,Yun; Hu,Shen Jiang; Fu,Michael. Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins. European Journal of Heart Failure 2009;11:6-13. (Link)

Rakonczay,Z.; Duda,E.; Kaszaki,J.; Ivanyi,B.; Boros,I.; Lonovics,J.; Takacs,T.. The anti-inflammatory effect of methylprednisolone occurs down-stream of nuclear factor-@kB DNA binding in acute... European Journal of Pharmacology 2003;464:217-227. (Link)

Letoha T,Somlai C,Takacs T,Szabolcs A,Jarmay K,Rakonczay Z Jr,Hegyi P,Varga I,Kaszaki J,Krizbai I,Boros I,Duda E,Kusz E,Penke B.. A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis. World J Gastroenterol. 2005;11:990-999. (Link)

Letoha T,Somlai C,Tak cs T,Szabolcs A,Rakonczay Z Jr,J rmay K,Szalontai T,Varga I,Kaszaki J,Boros I,Duda E,Hackler L,Kurucz I,Penke B.. The proteasome inhibitor MG132 protects against acute pancreatitis. Free Radic Biol Med. 2005;39:1145-1151. (Link)

Holmes,Anna G.; Mesa,Jose L.; Neill,Bronwyn A.; Chung,Jason; Carey,Andrew L.; Steinberg,Gregory R.; Kemp,Bruce E.; Southgate,Robert J.; Lancaster,Graeme I.; Bruce,Clinton R.; Watt,Matthew J.; Febbraio,Mark A.. Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPAR{alpha} and UCP2 expression in rats. Journal of Endocrinology 2008;198:367-374. (Link)

References: Helfgott,D.C.; Tatter,S.B.; Santhanam,U.; Clarick,R.H.; Bhardwaj,N.; May,L.T.; Sehgal,P.B.. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J.Immunol. 1989;142:948-953. (Link)

Ueyama,M.; Maruyama,I.; Osame,M.; Sawada,Y.. Marked increase in plasma interleukin-6 in burn patients. J.Lab Clin.Med. 1992;120:693-698. (Link)

May,L.T.; Santhanam,U.; Tatter,S.B.; Bhardwaj,N.; Ghrayeb,J.; Sehgal,P.B.. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. Biochem.Biophys.Res.Commun. 1988;152:1144-1150. (Link)

Martinez-Maza,O.. IL6 and AIDS. Res.Immunol. 1992;143:764-769. (Link)

Santhanam,U.; Avila,C.; Romero,R.; Viguet,H.; Ida,N.; Sakurai,S.; Sehgal,P.B.. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine 1991;3:155-163. (Link)

Nakajima,K.; Martinez-Maza,O.; Hirano,T.; Breen,E.C.; Nishanian,P.G.; Salazar-Gonzalez,J.F.; Fahey,J.L.; Kishimoto,T.. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J.Immunol. 1989;142:531-536. (Link)

Cayphas,S.; Van,Damme J.; Vink,A.; Simpson,R.J.; Billiau,A.; Van,Snick J.. Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection. J.Immunol. 1987;139:2965-2969. (Link)

Koj Aleksander. Regulation of the acute phase and immune responses: interleukin-6. Ann.N Y.Acad.Sci. 1989;557:1-583. (Link)

Hirano,T.; Matsuda,T.; Turner,M.; Miyasaka,N.; Buchan,G.; Tang,B.; Sato,K.; Shimizu,M.; Maini,R.; Feldmann,M.; .. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur.J.Immunol. 1988;18:1797-1801. (Link)

Sheron,N.; Bird,G.; Goka,J.; Alexander,G.; Williams,R.. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin.Exp.Immunol. 1991;84:449-453. (Link)

Zilberstein,A.; Ruggieri,R.; Korn,J.H.; Revel,M.. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986;5:2529-2537. (Link)

Helle,M.; Brakenhoff,J.P.; De Groot,E.R.; Aarden,L.A.. Interleukin 6 is involved in interleukin 1-induced activities. Eur.J.Immunol. 1988;18:957-959. (Link)

Pettersson,T.; Metsarinne,K.; Teppo,A.M.; Fyhrquist,F.. Immunoreactive interleukin-6 in serum of patients with B-lymphoproliferative diseases. J.Intern.Med. 1992;232:439-442. (Link)

Hirano,T.; Yasukawa,K.; Harada,H.; Taga,T.; Watanabe,Y.; Matsuda,T.; Kashiwamura,S.; Nakajima,K.; Koyama,K.; Iwamatsu,A.; .. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324:73-76. (Link)

Ray,A.; Tatter,S.B.; Santhanam,U.; Helfgott,D.C.; May,L.T.; Sehgal,P.B.. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann.N Y.Acad.Sci. 1989;557:353-361. (Link)

May,L.T.; Ghrayeb,J.; Santhanam,U.; Tatter,S.B.; Sthoeger,Z.; Helfgott,D.C.; Chiorazzi,N.; Grieninger,G.; Sehgal,P.B.. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J.Biol.Chem. 1988;263:7760-7766. (Link)

Hirano,T.; Taga,T.; Nakano,N.; Yasukawa,K.; Kashiwamura,S.; Shimizu,K.; Nakajima,K.; Pyun,K.H.; Kishimoto,T.. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc.Natl.Acad.Sci.U S A 1985;82:5490-5494. (Link)

Oka,Y.; Murata,A.; Nishijima,J.; Yasuda,T.; Hiraoka,N.; Ohmachi,Y.; Kitagawa,K.; Yasuda,T.; Toda,H.; Tanaka,N.; .. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992;4:298-304. (Link)

Horii,Y.; Iwano,M.; Hirata,E.; Shiiki,M.; Fujii,Y.; Dohi,K.; Ishikawa,H.. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int.Suppl 1993;39:S71-S75. (Link)

Ray,A.; Tatter,S.B.; Santhanam,U.; Helfgott,D.C.; May,L.T.; Sehgal,P.B.. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann.N.Y.Acad.Sci. 1989;557:353-361. (Link)

Hirano,T.; Akira,S.; Taga,T.; Kishimoto,T.. Biological and clinical aspects of interleukin 6. Immunol.Today 1990;11:443-449. (Link)

Elder,J.T.; Sartor,C.I.; Boman,D.K.; Benrazavi,S.; Fisher,G.J.; Pittelkow,M.R.. Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch.Dermatol.Res. 1992;284:324-332. (Link)

Merico,F.; Bergui,L.; Gregoretti,M.G.; Ghia,P.; Aimo,G.; Lindley,I.J.; Caligaris-Cappio,F.. Cytokines involved in the progression of multiple myeloma. Clin.Exp.Immunol. 1993;92:27-31. (Link)

Seguchi,T.; Yokokawa,K.; Sugao,H.; Nakano,E.; Sonoda,T.; Okuyama,A.. Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J.Urol. 1992;148:791-794. (Link)

Hirano,T.; Taga,T.; Yasukawa,K.; Nakajima,K.; Nakano,N.; Takatsuki,F.; Shimizu,M.; Murashima,A.; Tsunasawa,S.; Sakiyama,F.; .. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc.Natl.Acad.Sci.U.S.A 1987;84:228-231. (Link)